Bristol-Myers Poised to Close Celgene Deal After U.S. Nod

(Bloomberg) -- Bristol-Myers Squibb Co. won U.S. antitrust approval for its acquisition of Celgene Corp., the last regulatory approval needed for the blockbuster pharmaceutical deal.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.